Active, not recruitingNot applicableNCT02230839

Muscle Insulin Resistance in Aging (Mirage)

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AdventHealth Translational Research Institute
Principal Investigator
Bret Goodpaster, PhD
Translational Research Institute for Metabolism and Diabetes
Intervention
Exercise(behavioral)
Enrollment
200 target
Eligibility
65-80 years · All sexes
Timeline
20142025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02230839 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials